Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01471171 · COMPLETED
Trial details
- NCT number
- NCT01471171
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-06-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.